patient group Services
Strategic Planning
We offer strategic planning services helping patient groups create annual and long-term (3 to 5 year) plans, with associated implementation plans.
Access to Care
We work with you to develop an evidence-based advocacy approach, establishing a robust set of arguments that highlight the needs of the patients you represent.
Collaboration
We help you maximize your approach to collaborate with industry stakeholders, governmental agencies, other patient groups and the scientific communities relevant to your organisation.
Pharmaceutical/biotech services
Advisory Board
We assist in developing and implementing advisory board meetings with patients and patient groups in alignment with your brand and corporate strategies. We provide actionable advisory board output, including specific responses to your questions and a set of potential actions.
Access to Care
We have expertise in collaborating with external stakeholders to ensure they can provide relevant input in various HTA and reimbursement processes in multiple countries. This results in the development of an engagement plan, aligned with the regulatory and compliance framework. We also facilitate the development of patient input evidence, patient preference studies, consensus papers, and white papers.
Strategic Planning
We support pharmaceutical companies in updating or establishing their strategies, objectives and policies for collaborating with patient groups, locally or globally. We can help deliver a patient group engagement plan that is in alignment with your organisational objectives. Once a strategy is established, we provide communication materials for internal teams and other forms of implementation support.
Conference Support
Scientific conferences provide a key opportunity for pharmaceutical companies to network and meet with key industry stakeholders. We help you optimise your participation in these events by developing pre-event objectives, the list of key meetings to be held, and the development of pre-meeting briefings developed with input from numerous internal stakeholders.